This activity already occurred and is no longer available.
Molecular Imaging of Alzheimer's Disease
Bench to Bedside - Molecular Imaging of Alzheimer's Disease
Bench to Bedside - Molecular Imaging of Alzheimer's Disease

Release date: 10/12/12
Expiration date: 10/12/15


Authors
Tetsuya Suhara, MD, PhD, has nothing to disclose.
Chester A. Mathis, PhD, is a consultant for Bayer Healthcare, consultant for Elan Pharmaceuticals, consultant and investigator for GE Healthcare, consultant for IBA Molecular, consultant and investigator for Neuroptics, consultant for Novartis, and consultant for Takeda.
Alexander E. Drzezga, MD, has nothing to disclose.


Target Audience
Physicians, pharmacists, and technologists.

Objectives
At the completion of this activity, the participant will be able to:
1. Describe basic research techniques and emerging technologies relevant to Alzheimer's disease.
2. Review advances in translational research using molecular imaging techniques in animal studies or small human studies of dementia and Alzheimer's disease.
3. Explain state-of-the-art clinical molecular imaging relevant to dementing disorders.

Continuing Education Credit Information

AMA-PRA (Physician)
The Society for Nuclear Medicine and Medical Imaging, Inc. (SNMMI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

SNMMI designates this enduring material for a maximum of 1.5 AMA PRA Category 1 CreditTM. Physicians should claim only credit commensurate with the extent of their participation in the activity. To receive CE credit, learners must achieve a score of 80% on the post-course assessment and complete the evaluation. Release date: 10/12/12 Expiration date: 10/12/15.

   
ACPE (Pharmacists)
The Society for Nuclear Medicine and Molecular Imaging, Inc. (SNMMI) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity has been designated as knowledge-based CPE. The universal program number for this enduring material is 0210-0000-12-380-H04-P. Total available credit for pharmacists is 1.5 hours or 0.15 CEUs. Release date: 10/12/12 Expiration date: 10/12/15. To receive CE credit, learners must achieve a score of 80% on the post-course assessment and complete the evaluation.

VOICE (Technologists)
The SNMMI, through its Verification of Involvement in Continuing Education (VOICE) program, has approved this journal article for a maximum of 1.5 continuing education hours (CEHs). VOICE-approved credit is recognized by most licensure states and by the NMTCB and ARRT as Category A credit. In order to receive CE credit, you must first complete the activity content. When completed, take the post-test assessment.  You must obtain a score of 80% to receive the CE credit.  You will have no more than 3 attempts to successfully complete the post-test. Release date: 10/12/12 Expiration date: 10/12/15. California Scope: 1.5 Imaging(I)/Non-Imaging(NI) / Radiopharmacy(R) / Therapy(T).

Minimum system requirements

Supported Internet Browsers:
- Microsoft Internet Explorer (version 7 or higher)
- Google Chrome (latest version)
- Mozilla Firefox (latest version)
- Apple Safari (version 4 or higher)

Plug-in: Adobe Acrobat Reader (http://get.adobe.com/reader/)

For questions please contact the Education Department.
©2014 SNMMI. All rights reserved.   


Type:     Internet Activity (Enduring Material)
64 Registered Users